Clinical research professionals should be aware of the difficulties that biotech companies have in gaining access to high quality samples.
The funding for, and the number of, clinical trials for chronic kidney disease lag significantly behind its incidence and behind other diseases.
This column delivers news from academic medical centers pursuing clinical research activities vital to the advancement of healthcare.
Clinical Researcher—September 2021 (Volume 35, Issue 7) EXECUTIVE DIRECTOR’S MESSAGE Susan P. Landis, Executive Director of ACRP (susan.landis@acrpnet.org) We’ve been talking about you, and I hope your ears […]
Clinical Researcher—September 2021 (Volume 35, Issue 7) PEER REVIEWED Sucheta Sachdeva; Tyler D. Green; Terry L. Oroszi The COVID-19 pandemic has affected the health and productivity of employees in […]